CFGS
VKTX icon

Concourse Financial Group Securities’s Viking Therapeutics VKTX Stock Holding History

Concourse Financial Group Securities’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,450
Closed -$83.4K – 2004
2024
Q4 		$83.4K Buy
2,450
+1,750
+250% +$99.8K ﹤0.01% 1008
2024
Q3 		$44.3K Buy
700
+100
+17% +$5.87K ﹤0.01% 1230
2024
Q2 		$31.8K Buy
+600
New +$39.3K ﹤0.01% 1366
2022
Q1 		– Sell
-200
Closed -$717 – 2453
2021
Q4 		$1K Hold
200
– – ﹤0.01% 2328
2021
Q3 		$1K Hold
200
– – ﹤0.01% 2356
2021
Q2 		$1K Hold
200
– – ﹤0.01% 2320
2021
Q1 		$1K Buy
+200
New +$1.41K ﹤0.01% 2290
2020
Q4 		– Sell
-77
Closed -$466 – 2367
2020
Q3 		$0 Hold
77
– – ﹤0.01% 2271
2020
Q2 		$1K Hold
77
– – ﹤0.01% 2046
2020
Q1 		$0 Hold
77
– – ﹤0.01% 2329
2019
Q4 		$1K Buy
+77
New +$561 ﹤0.01% 2017
2019
Q3 		– Sell
-77
Closed -$572 – 2154
2019
Q2 		$1K Sell
77
-38
-33% -$325 ﹤0.01% 2147
2019
Q1 		$1K Sell
115
-39
-25% -$326 ﹤0.01% 2192
2018
Q4 		$1K Buy
+154
New +$1.84K ﹤0.01% 2056

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Concourse Financial Group Securities's VKTX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Viking Therapeutics (VKTX) in Q1 2025, closing a stake of 2,450 shares — an estimated $83.4K sold.

Concourse Financial Group Securities first reported a position in VKTX in Q4 2018 and held it in 14 quarters. The position peaked at $83.4K in Q4 2024. 372 funds tracked by Wall St. Rank hold VKTX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Viking Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 2,450 Viking Therapeutics shares in Q1 2025, an estimated $83.4K.
  • Concourse Financial Group Securities first reported a position in Viking Therapeutics in Q4 2018 and held it in 14 quarters.
  • Concourse Financial Group Securities's Viking Therapeutics position peaked at $83.4K in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.